Compare PLBY & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLBY | QSI |
|---|---|---|
| Founded | 1953 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.4M | 191.6M |
| IPO Year | 2020 | N/A |
| Metric | PLBY | QSI |
|---|---|---|
| Price | $1.35 | $0.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $3.00 | $1.00 |
| AVG Volume (30 Days) | 654.9K | ★ 6.1M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,928,000.00 | N/A |
| Revenue This Year | $9.17 | N/A |
| Revenue Next Year | $7.10 | $618.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.13 | N/A |
| 52 Week Low | $1.19 | $0.69 |
| 52 Week High | $2.75 | $3.10 |
| Indicator | PLBY | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 46.71 | 37.39 |
| Support Level | $1.23 | $0.69 |
| Resistance Level | $1.48 | $1.08 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 33.85 | 15.57 |
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.